Education - Dubai Students Create AI-Powered Drones Controlled by Voice Com… Transport - Uber to Invest Dh184 Million to Expand Driverless Taxi Services… Weather - More Rain Expected in Northern, Eastern and Coastal Areas on No…

Send an Inquiry

Fill in the details below and our team will get back to you.

Healthcare 1 min read 74 views

Breakthrough research shows kidney holds the key to managing Type 2 diabetes, reveals Kuwait medical symposium

A new treatment that centres on the kidney in managing Type 2 diabetes, and which has been approved in Europe and USA, has now been introduced in Kuwait. The highlights of the breakthrough development were discussed at a medical symposium held in Kuwait recently.

News of the innovative treatment comes at a time when nearly 17 million out of the 34.5 million people affected by diabetes in the MENA region are said to be undiagnosed and therefore are at considerable risk of diabetic complications. The figures were published in the 6th edition of the IDF Diabetes Atlas published by International Diabetes Federation (IDF). 1

Dr. Nabila Abdella Professor of Medicine - in Kuwait University Gulf said,Dr.waleed Al-dahi Consultant Endocrinology and Diabetes Mubarak Hospital and Dr.Magad Alsalah Head of Internal Medicine Mubarak Hospital: This should come as great news for Type 2 diabetics. With this discovery, medical science can be said to have achieved a breakthrough in the management of Type 2 diabetes with kidney as the focal point. We are delighted to announce that Forxiga the new treatment in managing type 2 diabetes is now available in the Kuwait, which demonstrates that the Kuwait remains at the forefront of accessibility to advanced healthcare.

Referring to the IDF report, Prof. Nabila , Dr.walid and DR.magda added: The report estimates the proportion of cases of undiagnosed diabetes based on population-based studies using either fasting blood glucose or oral glucose tolerance test, in a cross-sectional survey of people who were not earlier aware of their condition. The figure of undiagnosed cases of diabetes in the MENA Region is alarming and needs to be addressed at micro and macro levels.
The introduction of new oral treatment for managing Type 2 diabetes as Forxiga which is insulin Independent might change the way we treat patients in coming years. It spells good news for the advancement of healthcare globally and Kuwait, said Dr.Nabila.

Samer Al Hallaq, President, AstraZeneca Gulf, said: Millions of people in the Gulf are living with Type 2 diabetes due to a variety of factors. AstraZeneca is introducing a Robust Portfolio that includes three new classes in the NIAD (Non Insulin Anti-diabetic Market: DPP4, GLP-1& SGLT2) bringing innovation and scientific leadership that will benefit millions of diabetic patients across the globe, especially in the Gulf.

AstraZeneca Gulf has drawn up huge plans for its Diabetes Portfolio. The first in class SGLT-2 inhibitors was launched recently at this medical symposium in Kuwait.

Currently approved in more than 41 countries globally, the new treatment was the first SGLT2 inhibitor to gain regulatory approval to treat Type 2 diabetes in Europe in November 2012. It was approved by the US Food and Drug Administration for the treatment of adults with Type 2 diabetes on 8 January 2014, supported by a robust clinical development programme consisting of 24 clinical studies evaluating safety and efficacy.

Al Hallaq added: The significance of this treatment is that it works independently of insulin to help remove excess glucose from the body. The discovery of the hitherto unknown role of the kidney in treating diabetes will offer patient a solution to reducing blood glucose, weight and blood pressure.

Related News

More on Healthcare

View all

Comments (0)

Join the conversation

No comments yet. Be the first to share your thoughts!

More News

See all
Sports & Championship

From the Boardroom to the Racecourse: TAQA Executive Nabil Almessabi Prepares for World Triathlon Championships in Abu Dhabi

Nabil Almessabi, Chief Corporate Officer at TAQA Group, is preparing to compete in Friday’s Aquathlon at the 2026 World Triathlon Multisport Championships on Abu Dhabi’s Hudayriyat Island. Taking part in the age-group competition, the Emirati athlete hopes to represent the UAE proudly...

Nov 19, 2026 · 4 min
Tourism

Damascus Breaks Ground on Mövenpick Hotel and Arab Mall, Marking Accor’s Entry into Syria

Construction has officially begun on the Mövenpick Hotel and Arab Mall development in Kafr Sousa, Damascus, under the patronage of Syria’s Ministry of Tourism. Backed by investment from Rotana Star Holding and Sankari Holding, the project marks the entry of international hospitality...

Nov 19, 2026 · 3 min
Business

Middle East Businesses Urged to Strengthen Supply Chain Resilience Amid Climate Preparedness Gap

Businesses across the Middle East are being urged to strengthen their preparedness for climate-related supply chain disruption following new research by ACCA (the Association of Chartered Certified Accountants), which reveals significant gaps in organisations' ability to manage water-related...

Nov 19, 2026 · 4 min
Sports & Championship

FIA President Says Arrive and Drive World Cup Will Make Karting More Accessible Worldwide

FIA President Mohammed Ben Sulayem believes the FIA Karting Arrive and Drive World Cup can help expand international participation in karting by reducing the traditional financial and practical barriers to entering the sport. The second edition of the competition begins today at the LYL...

Nov 19, 2026 · 3 min
Trusted by

Our Associates

Brands and organisations that work with Day of Dubai.